Sale!

CKD (Chronic Kidney Disease) Management Panel Test

700 د.إ

-10%

The CKD (Chronic Kidney Disease) Management Panel Test is a comprehensive diagnostic tool designed to assess and monitor the functioning of the kidneys over time, specifically for individuals with or at risk of developing chronic kidney disease. Priced at 700 AED, this test is available at DNA Labs UAE, a leading facility in medical diagnostics. The panel typically includes a range of tests that evaluate kidney function and detect markers of kidney damage or disease. These may encompass measurements of serum creatinine, estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (ACR), and potentially other biomarkers relevant to kidney health. By providing a detailed picture of kidney function, the CKD Management Panel Test aids in the early detection of kidney disease, enabling timely intervention and management strategies to slow disease progression and maintain kidney health. DNA Labs UAE employs state-of-the-art technology and methodologies to ensure accurate and reliable test results, making it an excellent choice for those seeking to manage their kidney health proactively.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

CKD Chronic Kidney Disease Management Panel Test

Test Cost: AED 700.0

Test Components:

  • Z1014: CKD (Chronic Kidney Disease) Risk Map
  • Z007: Kidney Panel; KFT
  • B162: Bicarbonate, Serum
  • H001: Hemoglobin; Hb
  • R038: PTH (Parathyroid Hormone) Intact
  • R119: Vitamin D25 – Hydroxy

Price: 700.0 AED

Sample Condition:

  • 3 mL (1.5 mL min.) serum from 1 SST. Serum sample to be drawn between 8-10 am in a fasting condition. Allow blood to clot. Separate serum and freeze within 30 minutes.
  • 3 mL (1 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
  • 15 mL (10 mL min.) aliquot of first morning or random urine in a sterile screw capped container. First morning specimen of urine is preferred. Record patient’s age, gender, and height on test request form. Hemolysed samples not acceptable.

Report Delivery: Daily

Method:

Compensated Jaffe’s reaction, IDMS traceable, Immunoturbidimetry, Calculation, Spectrophotometry, Indirect ISE, CLIA, Photometry

Test Type: Renal Disorders

Doctor: Nephrologist

Test Department:

Pre Test Information:

Serum sample to be drawn between 8-10 am in a fasting condition. First morning specimen of urine is preferred. Record patient’s age, gender, and height on test request form.

Test Details:

The CKD management panel test is a series of blood tests that are used to monitor and manage chronic kidney disease (CKD). This panel typically includes the following tests:

  1. Creatinine: This test measures the level of creatinine in the blood, which is a waste product produced by the muscles. High levels of creatinine can indicate impaired kidney function.
  2. Blood urea nitrogen (BUN): This test measures the level of urea nitrogen in the blood, which is a waste product produced by the liver as it breaks down proteins. Elevated levels of BUN can indicate kidney dysfunction.
  3. Glomerular filtration rate (GFR): This test estimates the rate at which the kidneys are filtering waste products from the blood. A lower GFR indicates decreased kidney function.
  4. Electrolytes (sodium, potassium, and bicarbonate): These tests measure the levels of various electrolytes in the blood. Imbalances in electrolytes can occur with kidney dysfunction.
  5. Calcium and phosphate: These tests measure the levels of calcium and phosphate in the blood, which can be affected by kidney disease.
  6. Albumin: This test measures the level of albumin, a protein produced by the liver, in the blood. Low levels of albumin can indicate kidney damage.
  7. Hemoglobin and hematocrit: These tests measure the levels of hemoglobin and hematocrit in the blood, which can be affected by kidney disease.

These tests help healthcare providers assess the severity of CKD, monitor its progression, and determine appropriate treatment plans. Regular monitoring of these parameters is essential in managing CKD and preventing complications.

Test Name CKD CHRONIC KIDNEY DISEASE MANAGEMENT PANEL Test
Components *Z1014* CKD (CHRONIC KIDNEY DISEASE)RISK MAP *Z007* KIDNEY PANEL; KFT *B162* BICARBONATE, SERUM *H001* HEMOGLOBIN; Hb *R038* PTH (PARATHYROID HORMONE) INTACT *R119* VITAMIND25 – HYDROXY
Price 700.0 AED
Sample Condition 3 mL (1.5 mL min.) serum from 1 SST. Serum sample to be drawn between 8-10 am in a fasting condition.Allow blood to clot. Separate serum and freeze within 30 minutes AND3 mL (1 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE AND 15 mL (10 mL min.) aliquot of first morning or random urine in a sterile screw capped container. First morning specimen of urine is preferred. Record patient’s age, gender and height on test request form. Hemolysed samples not acceptable..
Report Delivery Daily
Method Compensated Jaffe??s reaction, IDMS traceable, Immunoturbidimetry, Calculation,Spectrophotometry, Indirect ISE ,CLIA ,Photometry
Test type Renal Disorders
Doctor Nephrologist
Test Department:
Pre Test Information Serum sample to be drawn between 8-10 am in a fasting condition. First morning specimen of urine is preferred. Record patient’s age, gender and height on test request form.
Test Details

The CKD management panel test is a series of blood tests that are used to monitor and manage chronic kidney disease (CKD). This panel typically includes the following tests:

1. Creatinine: This test measures the level of creatinine in the blood, which is a waste product produced by the muscles. High levels of creatinine can indicate impaired kidney function.

2. Blood urea nitrogen (BUN): This test measures the level of urea nitrogen in the blood, which is a waste product produced by the liver as it breaks down proteins. Elevated levels of BUN can indicate kidney dysfunction.

3. Glomerular filtration rate (GFR): This test estimates the rate at which the kidneys are filtering waste products from the blood. A lower GFR indicates decreased kidney function.

4. Electrolytes (sodium, potassium, and bicarbonate): These tests measure the levels of various electrolytes in the blood. Imbalances in electrolytes can occur with kidney dysfunction.

5. Calcium and phosphate: These tests measure the levels of calcium and phosphate in the blood, which can be affected by kidney disease.

6. Albumin: This test measures the level of albumin, a protein produced by the liver, in the blood. Low levels of albumin can indicate kidney damage.

7. Hemoglobin and hematocrit: These tests measure the levels of hemoglobin and hematocrit in the blood, which can be affected by kidney disease.

These tests help healthcare providers assess the severity of CKD, monitor its progression, and determine appropriate treatment plans. Regular monitoring of these parameters is essential in managing CKD and preventing complications.